Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 6,095 | 6,233 | 5,192 | 6,081 | 5,743 |
| Cost of Goods | 1,696 | 1,834 | 1,739 | 2,083 | 2,053 |
| Gross Profit | 4,399 | 4,398 | 3,453 | 3,998 | 3,690 |
| Operating Expenses | 10,723 | 8,863 | 8,477 | 9,666 | 6,454 |
| Operating Income | -5,628 | -3,630 | -4,285 | -5,585 | -2,711 |
| Other Income | -1,258 | 83 | -599 | -437 | -294 |
| Pre-tax Income | -6,885 | -3,547 | -4,884 | -6,023 | -3,005 |
| Net Income Continuous | -6,885 | -3,547 | -4,884 | -5,403 | -3,005 |
| Net Income | $-6,885 | $-3,547 | $-4,884 | $-5,403 | $-3,005 |
| EPS Basic Total Ops | -0.21 | -0.11 | -0.15 | -0.17 | -0.10 |
| EPS Basic Continuous Ops | -0.21 | -0.11 | -0.15 | -0.17 | -0.10 |
| EPS Diluted Total Ops | -0.21 | -0.11 | -0.15 | -0.17 | -0.10 |
| EPS Diluted Continuous Ops | -0.21 | -0.11 | -0.15 | -0.17 | -0.10 |
| EBITDA(a) | $-5,457 | $-3,469 | $-4,123 | $-5,428 | $-2,548 |